-
European Expert Panel Consensus on Outpatient Administration of Teclistamab and Talquetamab in Patients With Multiple Myeloma: Feasibility, Key Considerations, and Future Directions
Lund, T., Khandanpour, C., Anguille, S. B., Kisro, J., Krauth, M. T., Lund, J., Nijhof, I., Ocio, E. M., Zamagni, E., Javelot, M., Albrecht, C., Cerezo, C. E. & Perrot, A., 2025, (E-pub ahead of print) In: European Journal of Haematology.Research output: Contribution to journal › Article* › Academic › peer-review
-
Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma
Smits, F., Groen, K., Levin, M.-D., Stege, C., van Kampen, R. J. W., van der Spek, E., Bilgin, Y. M., Thielen, N., Nijhof, I. S., Ludwig, I., de Waal, E. G. M., Sandberg, Y., Kentos, A., Timmers, G.-J., Regelink, J. C., Westerman, M., Heer, K. D., Vekemans, M.-C. M., Durdu-Rayman, N. & de Graauw, N. C. H. P. & 5 others, , 22 Nov 2024, (E-pub ahead of print) In: Blood.Research output: Contribution to journal › Article* › Academic › peer-review
-
Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes
Groen, K., Smits, F., Nasserinejad, K., Levin, M.-D., Regelink, J. C., Timmers, G.-J., de Waal, E. G. M., Westerman, M., Velders, G. A., de Heer, K., Leys, R. B. L., van Kampen, R. J. W., Stege, C. A. M., Seefat, M. R., Nijhof, I. S., van der Spek, E., Klein, S. K., van de Donk, N. W. C. J., Ypma, P. F. & Zweegman, S., 1 Jul 2024, In: HemaSphere. 8, 7, e85.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications
